Your browser is no longer supported. Please, upgrade your browser.
Settings
OPXA Opexa Therapeutics, Inc. daily Stock Chart
OPXA [NASD]
Opexa Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.73 Insider Own- Shs Outstand7.66M Perf Week-1.04%
Market Cap7.43M Forward P/E- EPS next Y- Insider Trans- Shs Float7.56M Perf Month22.48%
Income-5.30M PEG- EPS next Q-0.12 Inst Own3.30% Short Float7.09% Perf Quarter67.22%
Sales1.50M P/S4.95 EPS this Y44.90% Inst Trans-20.21% Short Ratio1.04 Perf Half Y18.14%
Book/sh0.21 P/B4.62 EPS next Y- ROA-132.30% Target Price1.00 Perf Year-71.81%
Cash/sh0.24 P/C4.13 EPS next 5Y- ROE-195.40% 52W Range0.50 - 4.38 Perf YTD5.42%
Dividend- P/FCF- EPS past 5Y33.10% ROI-296.00% 52W High-77.86% Beta2.05
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low93.98% ATR0.09
Employees9 Current Ratio5.40 Sales Q/Q- Oper. Margin- RSI (14)54.26 Volatility11.18% 10.08%
OptionableNo Debt/Eq0.00 EPS Q/Q70.60% Profit Margin- Rel Volume0.59 Prev Close1.07
ShortableYes LT Debt/Eq0.00 EarningsAug 24 AMC Payout- Avg Volume513.62K Price0.97
Recom3.00 SMA204.27% SMA508.65% SMA20016.40% Volume305,245 Change-9.36%
Oct-28-16Downgrade Maxim Group Buy → Hold
Oct-28-16Downgrade Chardan Capital Markets Buy → Neutral $6 → $1
Nov-04-15Initiated Chardan Capital Markets Buy
Sep-28-15Reiterated Maxim Group Buy $5 → $18
May-27-15Initiated Maxim Group Buy $5
May-30-14Initiated Aegis Capital Buy $4
Mar-30-10Initiated Rodman & Renshaw Mkt Outperform $6
Feb-20-07Initiated MDB Capital Group Buy $8
Sep-13-17 07:00AM  Opexa Therapeutics, Inc. Urges Shareholders to Vote FOR the Merger with Acer Therapeutics; The Merger will Not Go Forward Unless ALL Proposals are Approved ACCESSWIRE
Sep-11-17 07:00AM  Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Opexa Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals ACCESSWIRE
Aug-14-17 07:30AM  Opexa Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update ACCESSWIRE
Aug-09-17 07:00AM  Opexa Therapeutics Sets Date for Special Meeting of Shareholders ACCESSWIRE -7.50%
Jul-17-17 04:15PM  Cambridge rare disease startup Acer to go public through merger American City Business Journals
Jul-05-17 09:49AM  Company News for July 05, 2017 Zacks -14.53%
Jul-03-17 10:57AM  Opexa Shares Jump on Merger with Acer Therapeutics TheStreet.com +80.00%
10:32AM  Merger Monday: 9 M&A Firecrackers Ahead Of Market Holiday Benzinga
06:00AM  Acer Therapeutics and Opexa Therapeutics Sign Merger Agreement Accesswire
May-12-17 08:30AM  Opexa Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update Accesswire
Apr-01-17 01:04PM  OPEXA THERAPEUTICS, INC. Financials
Mar-30-17 09:09AM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017 Capital Cube
09:09AM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 30, 2017
Mar-28-17 04:13PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and +6.30%
04:01PM  Opexa Therapeutics Reports 2016 Year End Financial Results and Provides Corporate Update Accesswire
Feb-01-17 07:32AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisitio +5.26%
07:30AM  Opexa Facility Becomes Foundation for Contract Manufacturing and Development Organization for Cellular Therapies Accesswire
Jan-12-17 01:18PM  These 5 Stocks Under $10 Could Explode Higher Soon TheStreet.com +29.93%
01:18PM  These 5 Stocks Under $10 Could Explode Higher Soon
Dec-23-16 01:01PM  ETFs with exposure to Opexa Therapeutics, Inc. : December 23, 2016 Capital Cube -12.72%
01:01PM  ETFs with exposure to Opexa Therapeutics, Inc. : December 23, 2016
Dec-12-16 11:21AM  ETFs with exposure to Opexa Therapeutics, Inc. : December 12, 2016 -19.01%
Dec-01-16 11:43AM  ETFs with exposure to Opexa Therapeutics, Inc. : December 1, 2016
Nov-18-16 01:27PM  ETFs with exposure to Opexa Therapeutics, Inc. : November 18, 2016 Capital Cube +21.82%
01:27PM  ETFs with exposure to Opexa Therapeutics, Inc. : November 18, 2016
Nov-15-16 12:19PM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016 Capital Cube
12:19PM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
Nov-14-16 07:32AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:30AM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
07:25AM  Opexa Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update Accesswire
Nov-03-16 01:51PM  Biotech Movers on Thursday: Cempra Inc (CEMP) And Opexa Therapeutics Inc (OPXA) Insider Monkey
01:51PM  Biotech Movers on Thursday: Cempra Inc (CEMP) And Opexa Therapeutics Inc (OPXA) at Insider Monkey
Nov-02-16 07:46AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors o -20.41%
07:30AM  Opexa Announces Reduction in Workforce in Light of Top-Line Results from Phase 2b Abili-T Trial of Tcelna(R) (imilecleucel-T) in Secondary Progressive Multiple Sclerosis Accesswire
Oct-29-16 09:45AM  6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Oct-28-16 11:53AM  GNC Deal Could Be In Jeopardy, Genocea Taming Herpes, Opexa Not Taming MS, Plus The Latest on Theravance at Insider Monkey -69.12%
11:29AM  Opexa Therapeutics downgraded by Chardan Capital Markets and Maxim Group
10:25AM  Is This the Beginning of the End of Opexa?
08:36AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  Opexa Therapeutics Announces Phase 2b Abili-T Trial of Tcelna(R) (imilecleucel-T) in Secondary Progressive Multiple Sclerosis Did Not Meet Primary Endpoint Accesswire
Oct-17-16 10:32AM  ETFs with exposure to Opexa Therapeutics, Inc. : October 17, 2016
Oct-05-16 10:34AM  ETFs with exposure to Opexa Therapeutics, Inc. : October 5, 2016 +5.48%
Sep-12-16 08:31AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-07-16 08:30AM  Opexa Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference Marketwired
Aug-12-16 02:38PM  ETFs with exposure to Opexa Therapeutics, Inc. : August 12, 2016
Aug-11-16 04:07PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Opexa Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update Marketwired
07:07AM  Q2 2016 Opexa Therapeutics Inc Earnings Release - After Market Close
Aug-09-16 08:30AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2016 Financial Results Marketwired
Jul-19-16 12:57PM  ETFs with exposure to Opexa Therapeutics, Inc. : July 19, 2016
Jul-01-16 05:19PM  5 Top Biotech Performers of 2016
May-18-16 04:07PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
01:48PM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: Q1, 2016 By the Numbers
May-12-16 04:10PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -9.62%
04:09PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Opexa Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update Marketwired
07:07AM  Q1 2016 Opexa Therapeutics Inc Earnings Release - After Market Close
May-10-16 09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2016 Financial Results Marketwired
Apr-27-16 08:30AM  Opexa to Attend the Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact Marketwired
Apr-11-16 06:51PM  Edited Transcript of OPXA earnings conference call or presentation 15-Mar-16 8:30pm GMT
Mar-25-16 04:25PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material De
Mar-17-16 02:25PM  Opexa Therapeutics, Inc. :OPXA-US: Earnings Analysis: 2015 By the Numbers +5.05%
Mar-15-16 04:07PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fi
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
04:01PM  Opexa Therapeutics Reports 2015 Year End Financial Results and Provides Corporate Update Marketwired
07:07AM  Q4 2015 Opexa Therapeutics Inc Earnings Release - After Market Close
Mar-14-16 09:00AM  Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2015 Financial Results Marketwired
Mar-02-16 04:07PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors o
04:00PM  Opexa Launches Restructuring Initiative to Focus Use of Resources Ahead of Key Phase 2 Data Expected in Early Q4 2016 Marketwired
Jan-29-16 02:24PM  Opexa Therapeutics to Present at the 18th Annual BIO CEO and Investor Conference at noodls
Jan-28-16 09:00AM  Opexa Therapeutics to Present at the 18th Annual BIO CEO and Investor Conference Marketwired
Dec-08-15 11:33AM  Opexa Therapeutics, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Nov-24-15 04:31PM  Logic Has Nothing to Do With This Market +12.17%
01:20PM  Computer Games Play the Market
11:18AM  4 Stocks to Watch That are Trading Up Today on Heavy Volume Accesswire
10:39AM  And Here Are the Dip Buyers
Nov-17-15 08:00AM  Opexa Therapeutics Chosen as One of the Top Autoimmune Therapy Projects to Watch Business Wire
Nov-10-15 04:11PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
04:06PM  OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Opexa Therapeutics Announces Supportive Preclinical Study Results for its Neuromyelitis Optica (NMO) Program Business Wire
04:01PM  Opexa Therapeutics Reports Third Quarter 2015 Financial Results and Provides Corporate Update Business Wire
07:07AM  Q3 2015 Opexa Therapeutics Inc Earnings Release - After Market Close
Nov-06-15 08:30AM  Opexa Therapeutics Announces News Release Schedule for Third Quarter 2015 Financial Results Business Wire
Nov-04-15 08:41AM  Chardan Starts Opexa Therapeutics With Buy Rating, $6 Price Target +14.85%
Oct-20-15 07:30PM  Edited Transcript of OPXA earnings conference call or presentation 12-Aug-15 9:00pm GMT -5.15%
Oct-19-15 08:11AM  Opexa Therapeutics to Host Analyst and Investor Event on November 10 in New York Business Wire
Oct-15-15 08:59AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.23%
08:00AM  Opexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement Business Wire
Oct-13-15 07:00AM  Opexa Therapeutics to Present at BIO Investor Forum Business Wire
Oct-08-15 09:15AM  SeeThruEquity Issues Update on Opexa Therapeutics, Inc. (NASDAQ: OPXA) Highlighting New Patents and Reverse Stock Split Accesswire
Oct-06-15 07:00AM  Opexa Announces Granting of New T-cell Patents Covering Tcelna®; Patent Estate Increases to 160 Issued Patents Business Wire +9.48%
Oct-01-15 10:26AM  Opexa Therapeutics, Inc. Earnings Q2, 2015
Sep-29-15 07:03AM  Splits Calendar: Opexa Therapeutics splits before market open today (1:8 ratio) -15.65%
Sep-28-15 07:03AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Artic -21.89%
07:00AM  Opexa Announces Reverse Stock Split Business Wire
Sep-10-15 09:15AM  SeeThruEquity Issues Update on Opexa Therapeutics, Inc. (NASDAQ: OPXA) Highlighting NMO Program Accesswire
Sep-03-15 04:31PM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Sep-02-15 10:10AM  Taglich Brothers Initiates Coverage on Opexa Therapeutics, Inc. Marketwired
06:05AM  OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company's lead product candidate is Tcelna, a T-cell immunotherapy for the treatment of patients with secondary progressive MS. It is also developing OPX-212, an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARABE TIMOTHY CDirectorNov 18Sale0.5514,9148,21012,910Nov 22 07:31 AM
AHGP Alliance Holdings GP, L.P. daily Stock Chart
AHGP [NASD]
Alliance Holdings GP, L.P.
Index- P/E7.84 EPS (ttm)3.46 Insider Own70.16% Shs Outstand57.00M Perf Week2.15%
Market Cap1.55B Forward P/E8.08 EPS next Y3.36 Insider Trans0.00% Shs Float17.86M Perf Month3.75%
Income207.30M PEG0.56 EPS next Q0.91 Inst Own21.80% Short Float0.39% Perf Quarter18.05%
Sales1.94B P/S0.80 EPS this Y-12.00% Inst Trans-9.96% Short Ratio0.72 Perf Half Y0.93%
Book/sh10.26 P/B2.65 EPS next Y0.60% ROA9.40% Target Price32.00 Perf Year8.52%
Cash/sh0.77 P/C35.16 EPS next 5Y14.00% ROE35.20% 52W Range22.71 - 32.70 Perf YTD-3.42%
Dividend2.92 P/FCF2.30 EPS past 5Y-2.80% ROI29.20% 52W High-17.00% Beta0.57
Dividend %10.76% Quick Ratio0.70 Sales past 5Y0.90% Gross Margin39.30% 52W Low19.51% ATR0.79
Employees3324 Current Ratio1.10 Sales Q/Q-9.20% Oper. Margin20.40% RSI (14)55.13 Volatility3.38% 2.88%
OptionableYes Debt/Eq0.91 EPS Q/Q-6.10% Profit Margin10.70% Rel Volume0.98 Prev Close27.10
ShortableYes LT Debt/Eq0.74 EarningsJul 31 BMO Payout63.50% Avg Volume95.77K Price27.14
Recom3.00 SMA201.37% SMA502.08% SMA200-2.08% Volume93,622 Change0.15%
Nov-01-10Reiterated Barclays Capital Overweight $48 → $53
Jan-28-10Upgrade Wells Fargo Underperform → Market Perform
Mar-27-09Downgrade Stifel Nicolaus Buy → Hold
Jan-22-09Reiterated Barclays Capital Overweight $32 → $25
Jul-09-08Reiterated Lehman Brothers Overweight $32 → $36
Mar-07-08Upgrade Stifel Nicolaus Hold → Buy $28
Feb-05-08Reiterated Lehman Brothers Overweight $28 → $30
Aug-17-07Downgrade AG Edwards Buy → Hold
Aug-02-07Downgrade Stifel Nicolaus Buy → Hold
Jul-18-07Reiterated AG Edwards Buy $31 → $36
May-08-07Reiterated AG Edwards Buy $26 → $31
Apr-09-07Reiterated Stifel Nicolaus Buy $25 → $27
Sep-20-17 08:08AM  Here's Why Alliance Holdings is an Attractive Pick for Now Zacks
Sep-12-17 05:42PM  Alliance Holdings GP LP : AHGP-US: Dividend Analysis : August 11th, 2017 (record date) : By the numbers : September 12, 2017 Capital Cube
11:24AM  Alliance Holdings GP LP breached its 50 day moving average in a Bearish Manner : AHGP-US : September 12, 2017 Capital Cube
Sep-07-17 08:48AM  Alliance Holdings GP LP :AHGP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017 Capital Cube
Aug-15-17 05:31PM  Alliance Holdings GP LP Value Analysis (NASDAQ:AHGP) : August 15, 2017 Capital Cube
Aug-10-17 08:39AM  Why Alliance Holdings (AHGP) is Such a Great Value Stock Pick Right Now Zacks
Aug-03-17 04:16PM  Why One Coal Mining Name Rocketed 20% in July Motley Fool
Aug-01-17 03:13PM  Alliance Holdings GP LP: Leads amongst peers with strong fundamentals Capital Cube
08:11AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : August 1, 2017 Capital Cube
07:30AM  Corporate News Blog - Alliance Resource Partners and Alliance Holdings GP Announce Elimination of IDRs and Conversion of General Partner Interest for 56.1 Million ARLP Units ACCESSWIRE
Jul-31-17 04:30PM  Why Dynavax Technologies, Alliance Holdings, and Sohu.com Jumped Today Motley Fool +12.63%
04:00PM  Alliance Resource Partners, L.P.'s Financial Results Slip on Lower Coal Prices Motley Fool
07:00AM  Alliance Holdings GP, L.P. Reports Quarterly Financial Results and Increases Quarterly Distribution by 32.7% to $0.73 Per Unit Business Wire
Jul-28-17 04:15PM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Announce Elimination of IDRs and Conversion of General Partner Interest in Exchange for 56.1 Million ARLP Units; Unitholder Distribution Increased 14.3% at ARLP and 32.7% at AHGP Business Wire
Jul-17-17 10:00AM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Announce Second Quarter 2017 Earnings Conference Call Business Wire
Jun-28-17 09:13AM  Should Alliance Holdings (AHGP) Be Part of Your Portfolio? Zacks
Jun-20-17 09:03AM  Alliance Holdings (AHGP) in Focus: Stock Moves 7.6% Higher Zacks
Jun-15-17 12:58PM  ETFs with exposure to Alliance Holdings GP LP : June 15, 2017 Capital Cube
Jun-14-17 08:10AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : June 14, 2017 Capital Cube
Jun-13-17 12:00PM  3 Top Dividend Stocks in Mining Motley Fool +5.02%
09:30AM  Zacks Industry Outlook Highlights: Arch Coal, CONSOL Energy, CNX Coal Resources, Alliance Holdings GP and Alliance Resource Partners Zacks
Jun-12-17 03:24PM  Coal Industry Poised to Benefit from Trump's Accommodations Zacks
09:30AM  Zacks Industry Outlook Highlights: Arch Coal, Peabody Energy, Alliance Holdings GP and Alliance Resource Partners Zacks
Jun-09-17 03:25PM  Coal Industry Outlook - June 2017 Zacks
Jun-01-17 08:43AM  Why Alliance Holdings (AHGP) is Such a Great Value Stock Pick Right Now Zacks
08:13AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : June 1, 2017 Capital Cube
May-31-17 12:19PM  ETFs with exposure to Alliance Holdings GP LP : May 31, 2017 Capital Cube
May-30-17 08:56AM  Alliance Holdings GP LP :AHGP-US: Earnings Analysis: Q1, 2017 By the Numbers : May 30, 2017 Capital Cube
May-18-17 07:00AM  Alliance to Present at the Master Limited Partnership Association's 2017 Master Limited Partnership Investor Conference Business Wire
May-17-17 10:24AM  New Strong Buy Stocks for May 17th Zacks
May-10-17 01:32PM  Alliance Holdings GP LP : AHGP-US: Dividend Analysis : May 12th, 2017 (record date) : By the numbers : May 10, 2017 Capital Cube
May-03-17 04:34PM  Alliance Holdings GP LP Value Analysis (NASDAQ:AHGP) : May 3, 2017 Capital Cube
May-02-17 02:14PM  Alliance Holdings GP LP: Leads amongst peers with strong fundamentals Capital Cube
08:04AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : May 2, 2017 Capital Cube
May-01-17 07:00AM  Alliance Holdings GP, L.P. Reports Quarterly Financial Results; Declares Quarterly Distribution of $0.55 Per Unit Business Wire +10.36%
Apr-28-17 04:15PM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Declare First Quarter 2017 Unitholder Distribution Business Wire
Apr-18-17 08:15AM  Post Earnings Coverage as Dominion Diamond Posted Quarterly Profit Accesswire
Apr-17-17 07:00AM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Announce First Quarter 2017 Earnings Conference Call Business Wire
Apr-07-17 03:44PM  ETFs with exposure to Alliance Holdings GP LP : April 7, 2017 Capital Cube
09:55AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : April 7, 2017 Capital Cube
Apr-03-17 07:07AM  ALLIANCE HOLDINGS GP, L.P. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhib
Mar-30-17 09:30AM  The Zacks Analyst Blog Highlights: Alliance Holdings GP, Arch Coal, Alliance Resource Partners and CONSOL Energy Zacks
09:30AM  The Zacks Analyst Blog Highlights: Alliance Holdings GP, Arch Coal, Alliance Resource Partners and CONSOL Energy at Investopedia
Mar-29-17 04:33PM  Are Coal Stocks the Big Winners from the Climate Rule Repeal? Zacks +6.61%
10:23AM  Enbridge Buys Spectra, Strengthens Hold in North America
10:23AM  Enbridge Buys Spectra, Strengthens Hold in North America Investopedia
10:23AM  Enbridge Buys Spectra, Strengthens Hold in North America at Investopedia
Mar-27-17 11:32AM  Top Ranked Income Stocks to Buy for March 27th
Mar-23-17 10:21AM  Enbridge to Cut 1000 Jobs Following Merger with Spectra
Mar-22-17 11:45AM  Alliance Holdings GP LP : AHGP-US: Dividend Analysis : February 10th, 2017 (record date) : By the numbers : March 22, 2017 Capital Cube
11:45AM  Alliance Holdings GP LP : AHGP-US: Dividend Analysis : February 10th, 2017 (record date) : By the numbers : March 22, 2017
09:47AM  Statoil Cuts Johan Sverdrup Oilfield Development Cost Again Zacks
Mar-16-17 10:05AM  Is Alliance Holdings a Good Stock for Value Investing? Zacks
Mar-07-17 09:59AM  Top Ranked Income Stocks to Buy for March 7th
Mar-02-17 01:04PM  ALLIANCE HOLDINGS GP, L.P. Financials
Mar-01-17 09:56AM  Top Ranked Income Stocks to Buy for March 1st
09:06AM  5 Top-Ranked Dividend Stocks to Buy in March
Feb-24-17 02:12PM  ALLIANCE HOLDINGS GP, L.P. Files SEC form 10-K, Annual Report
Feb-22-17 09:22AM  Top Ranked Income Stocks to Buy for February 22nd
Feb-17-17 02:39PM  Coal Showing Signs of Turnaround: Solid Long-Term Choice Zacks
09:57AM  Top Ranked Momentum Stocks to Buy for February 17th
08:20AM  Cloud Peak Energy (CLD) Shows Strength: Stock Up 10.4%
Feb-13-17 01:26PM  This Energy Stock Went on a Stunning Run in 2016 and Might Keep its Momentum in 2017 Motley Fool
Feb-10-17 09:04AM  Top Ranked Income Stocks to Buy for February 10th Zacks
Feb-07-17 08:33AM  Earnings Estimates Moving Higher for Alliance Holdings (AHGP): Time to Buy? Zacks
Feb-03-17 08:33AM  Implied Volatility Surging for Alliance Holdings (AHGP) Stock Options
Feb-02-17 12:45PM  ALLIANCE HOLDINGS GP, L.P. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Finan
12:16PM  ETFs with exposure to Alliance Holdings GP LP : February 2, 2017
Feb-01-17 01:44PM  Alliance Holdings GP LP :AHGP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 1, 2017
Jan-31-17 12:39PM  Alliance Holdings GP LP :AHGP-US: Earnings Analysis: 2016 By the Numbers : January 31, 2017
Jan-30-17 10:00AM  Alliance Resource Partners LP and Alliance Holdings GP LP Earnings Call scheduled for 10:00 am ET today
08:07AM  ALLIANCE HOLDINGS GP, L.P. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
07:14AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : January 30, 2017
07:07AM  Q4 2016 Alliance Holdings GP LP Earnings Release - Before Market Open
07:00AM  Alliance Holdings GP, L.P. Reports Quarterly and Full Year Financial Results; Maintains Quarterly Distribution of $0.55 Per Unit Business Wire
Jan-27-17 04:15PM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Declare Fourth Quarter 2016 Unitholder Distribution Business Wire
Jan-13-17 07:00AM  Alliance Resource Partners, L.P. and Alliance Holdings GP, L.P. Announce Fourth Quarter 2016 Earnings Conference Call Business Wire
Jan-09-17 02:51PM  Alliance Holdings GP LP : AHGP-US: Dividend Analysis : November 10th, 2016 (record date) : By the numbers : January 9, 2017
Jan-06-17 09:10AM  A Reduced Payout Could Be Imminent for These High-Yield Dividend Stocks at Motley Fool
Dec-28-16 07:09AM  Alliance Holdings GP LP breached its 50 day moving average in a Bullish Manner : AHGP-US : December 28, 2016
Dec-27-16 04:28PM  Nasdaq Carves New High, Dow And S&P 500 Drift Up; Fertilizers Rally +5.48%
Dec-22-16 09:30AM  Zacks Investment Ideas feature highlights: Alliance Holdings GP, SunCoke Energy and Cloud Peak Energy
Dec-21-16 01:59PM  Nothing Naughty About These Coal Stocks
11:51AM  2 Great Stocks You Can Buy on Sale at Motley Fool
Dec-20-16 10:51AM  These 2 Hated Dividend Stocks Are Buys at Motley Fool
Dec-16-16 10:17AM  Alliance Holdings GP LP Value Analysis (NASDAQ:AHGP) : December 16, 2016
09:32AM  Top Ranked Income Stocks to Buy for December 16th
Dec-15-16 07:27AM  Alliance Holdings GP LP breached its 50 day moving average in a Bearish Manner : AHGP-US : December 15, 2016
Dec-13-16 12:23PM  While Global Coal Prices Go Hyperbolic, Alliance Holdings GP, L.P. Will Be Left in the Dust at Motley Fool
Dec-09-16 09:32AM  Top Ranked Income Stocks to Buy for December 9th
08:30AM  Alerian Index Series December 2016 Index Review PR Newswire
Dec-07-16 11:37AM  Top Ranked Income Stocks to Buy for December 7th
Dec-02-16 09:25AM  Top Ranked Income Stocks to Buy for December 2nd
Dec-01-16 04:45PM  5 Oil Stocks to Shine on OPEC Deal
04:28PM  These Are Alliance Holdings GP, L.P.'s Smartest Moves of 2016 at Motley Fool
Nov-30-16 11:27AM  Top Ranked Income Stocks to Buy for November 30th
Nov-29-16 01:57PM  ETFs with exposure to Alliance Holdings GP LP : November 29, 2016
Nov-28-16 06:15PM  3 Low Cost, High Dividend Yield Stocks To Buy Now
07:32AM  Alliance Holdings GP LP breached its 50 day moving average in a Bearish Manner : AHGP-US : November 28, 2016
Nov-22-16 12:32PM  The Aftermath of a U.S. Election
Alliance Holdings GP, L.P., together with its subsidiaries, produces and markets coal primarily to utilities and industrial users in the United States. It operates in two segments, Illinois Basin and Appalachia. The company operates eight underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia. It also leases land and operates a coal loading terminal on the Ohio River at Mt. Vernon, Indiana; and purchases and resells coal. In addition, the company offers various industrial and mining technology products and services; and miner and equipment tracking systems, and proximity detection systems. At December 31, 2016, it had approximately 1.76 billion tons of proven and probable coal reserves in Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia. Alliance GP, LLC serves as the general partner of the company. The company was founded in 2005 and is headquartered in Tulsa, Oklahoma.
PRAN Prana Biotechnology Limited daily Stock Chart
PRAN [NASD]
Prana Biotechnology Limited
Index- P/E- EPS (ttm)-4.07 Insider Own18.70% Shs Outstand8.70M Perf Week1.79%
Market Cap24.79M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.15M Perf Month9.62%
Income-6.00M PEG- EPS next Q- Inst Own1.80% Short Float1.27% Perf Quarter16.80%
Sales0.10M P/S247.95 EPS this Y2.40% Inst Trans10.59% Short Ratio1.11 Perf Half Y27.23%
Book/sh12.79 P/B0.22 EPS next Y- ROA-23.60% Target Price18.00 Perf Year-43.11%
Cash/sh2.01 P/C1.42 EPS next 5Y- ROE-25.40% 52W Range1.52 - 5.14 Perf YTD74.85%
Dividend- P/FCF- EPS past 5Y4.90% ROI-41.70% 52W High-44.55% Beta-0.25
Dividend %- Quick Ratio15.90 Sales past 5Y-6.60% Gross Margin- 52W Low87.50% ATR0.18
Employees15 Current Ratio15.90 Sales Q/Q-38.60% Oper. Margin- RSI (14)57.14 Volatility5.67% 6.83%
OptionableNo Debt/Eq0.00 EPS Q/Q18.80% Profit Margin- Rel Volume0.24 Prev Close2.76
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume93.96K Price2.85
Recom- SMA206.33% SMA505.81% SMA20015.55% Volume22,271 Change3.26%
Mar-31-14Downgrade MLV & Co Buy → Hold $11 → $3
Mar-31-14Downgrade HC Wainwright Buy → Neutral $33 → $5
Feb-18-14Initiated HC Wainwright Buy $20.50
Dec-20-12Initiated Burrill Institutional Research Mkt Outperform $5
Oct-04-11Initiated MLV Capital Buy $6
Sep-09-08Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $8
Jul-18-17 09:00AM  Prana Commences Research Collaboration with Takeda for the Treatment of Parkinson's Disease Gastrointestinal Neuropathology Business Wire +7.95%
Jul-05-17 09:00AM  Prana's PBT434 Lowers Alpha-Synuclein and Prevents Neurodegeneration Business Wire
08:00AM  Today's Research Reports on Stocks to Watch: Opexa Therapeutics and Prana Biotechnology Accesswire
Jun-05-17 08:30AM  Prana Appoints David Stamler as Chief Medical Officer to Lead Clinical Development Business Wire
Mar-31-17 09:30AM  Prana Biotechnology and Xenetic Biosciences Expand Their Product Promotion Accesswire -7.94%
Oct-18-16 11:00AM  New Data from Reach2HD Trial Presented at American Neurological Association Annual Meeting Business Wire
Oct-08-16 01:04PM  PRANA BIOTECHNOLOGY LTD Financials
Jul-27-16 12:22PM  Prana Alzheimer's disease data features at world leading conference Business Wire
Jun-22-16 02:54PM  Five Stocks on the Move Today Amid a Mixed Market Insider Monkey +6.90%
02:54PM  Five Stocks on the Move Today Amid a Mixed Market at Insider Monkey
Apr-11-16 08:00AM  Prana Regains Compliance with NASDAQ Continued Listing Requirements Continues to Work Towards FDA Submission Other +7.32%
Feb-26-16 08:00AM  Prana Biotechnology Half Year Investor Report Other
Nov-16-15 09:00AM  Prana Chief Scientific Advisor Receives Smithsonian American Ingenuity Award Business Wire
Nov-09-15 08:00AM  Prana Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement Business Wire
Aug-27-15 08:00AM  Prana Reports FY15 Financial Results Business Wire
Jun-30-15 11:58PM  Prana Announces Safety Outcomes of Alzheimers IMAGINE Extension Trial Business Wire
Jun-01-15 09:00AM  European Commission Approves PBT2 Orphan Designation for Huntingtons Disease Business Wire
Apr-27-15 11:22PM  PBT2 Recommended for Orphan Designation in Europe Other
Mar-10-15 02:01PM  4 Stocks Under $10 to Trade for Big Breakouts TheStreet.com
Feb-13-15 12:40PM  Broker does a 180 on Glaxo; shares surge at MarketWatch
Jan-01-15 11:52AM  The Worst-Performing Biotech Stocks Of 2014 Forbes
Nov-19-14 11:00AM  The Lancet Neurology Publishes Prana's Huntington Disease Trial Other
Oct-07-14 01:00PM  Horizon Pharma's Actimmune Gets Orphan Drug Designation Zacks
Sep-08-14 04:35PM  Prana Biotechnology Up on Orphan Drug Status for PBT2 Zacks
Sep-05-14 04:49PM  US STOCKS-S&P 500 ends at record as jobs report eases Fed worries Reuters
02:17PM  US STOCKS-Wall St rises as weak payrolls ease Fed worries Reuters
12:17PM  US STOCKS-Wall St flat following weak payrolls report Reuters
10:35AM  Huntingtons Disease Orphan Drug Designation Could Rescue Prana at 24/7 Wall St.
10:17AM  US STOCKS-Wall St little changed after weak payrolls report Reuters
09:46AM  Why Prana Biotechnology (PRAN) Stock Is Surging Today at TheStreet
09:15AM  US STOCKS-Wall St set to dip at open after payrolls report Reuters
08:00AM  US STOCKS-Futures dip before payrolls; on track for weekly fall Reuters
07:45AM  Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease PR Newswire
Aug-29-14 07:00AM  3 Biotech Stocks Under $10 in Breakout Territory at TheStreet
Jul-17-14 04:27PM  Prana updates Alzheimer disease development program theflyonthewall.com
04:10PM  Prana Alzheimer's disease Development Program update PR Newswire
02:05PM  Why Prana Biotechnology (PRAN) Stock Is Surging Today at TheStreet
Jul-11-14 06:46AM  5 Stocks Under $10 Set to Soar at TheStreet
Jun-26-14 01:56PM  5 Stocks Under $10 Setting Up to Soar at TheStreet
Jun-19-14 06:00AM  4 Stocks Under $10 to Trade for Breakouts at TheStreet
Jun-11-14 06:30AM  3 Stocks Under $10 Making Big Moves at TheStreet
May-28-14 11:33AM  Here's the Next Small-Cap Stock the Spec Money Will Chase at TheStreet
09:00AM  Prana rises 7.9% at theflyonthewall.com
May-27-14 03:28PM  Prana Biotechnology (PRAN) Stock Suddenly Surges Other
May-14-14 07:30AM  World leader in movement disorders Professor Ira Shoulson joins Prana Board PR Newswire
Apr-30-14 01:26PM  Biotech and the Fallacy of Analyst Ratings at Motley Fool
Apr-23-14 09:01AM  Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited Business Wire
Apr-22-14 02:05PM  A Beaten-Down Biotech Stock Poised to Perk Up at TheStreet
Apr-14-14 04:15PM  Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure Other
11:16AM  Are These Three Biotech Companies Still Worth A Gamble? at Seeking Alpha
Apr-13-14 11:09AM  Nasdaq Falls Below 4,000 on Biotech, Technology Weakness at 24/7 Wall St.
Apr-08-14 09:34AM  The Worst Biotech Failures of the Week at Motley Fool
Apr-05-14 02:15PM  This Week in Biotech: Data Disappointments Come in Threes at Motley Fool
Apr-04-14 08:43AM  3 Stocks Under $10 Making Big Moves at TheStreet
07:00AM  Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries at TheStreet
Apr-01-14 02:10PM  Will Pranas Implosion Go All the Way? 24/7 Wall St.
10:13AM  Why Prana Biotechnology (PRAN) Stock Is Down Today Other
Mar-31-14 07:35PM  Big Movers Today: Panera, Delta, GM, and Prana Biotechnology at Motley Fool
07:03PM  Down 70%: Is Prana Biotechnology Ltd. a Buy? Other
03:21PM  Why Prana Biotechnology Limited Got Pummeled at Motley Fool
12:40PM  Biotech's shares fall 70% on tests at MarketWatch
12:18PM  Midday Movers: Amgen, Biogen, Priceline & More at CNBC
12:18PM  On The Fly: Midday Wrap at theflyonthewall.com
10:42AM  Prana tumbles after Alzheimer's drug study does not hit endpoint at theflyonthewall.com
10:37AM  J&J sells Ortho-Clinical; BlackBerry extends losses at MarketWatch
10:27AM  Wall Street Notches Slight Gains for the Month and the Quarter at New York Times
09:05AM  Stocks to Watch: Biofuel Energy, GM, Prana Biotechnology Other
09:00AM  Ahead of the Bell: Prana Biotechnology shares skid AP
08:45AM  Prana Biotech downgraded by HC Wainwright Briefing.com
08:20AM  Biotech Firm Prana Misses Goal on Alzheimer Drug Other
07:49AM  U.S.-listed shares of Prana sink after drug trial at MarketWatch
07:05AM  Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease PR Newswire
06:54AM  Prana Alzheimer's Study Fails at TheStreet
Mar-21-14 04:09PM  3 Biotechs Expecting Data at Motley Fool
Mar-20-14 03:49PM  Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors at Seeking Alpha
Mar-07-14 08:38AM  Alzheimer's Research Stocks - Technical And Other Considerations at Seeking Alpha
Mar-04-14 03:24PM  Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? at Seeking Alpha
Mar-03-14 01:13PM  A Busy Calendar of March Biotech Events at TheStreet
09:38AM  Prana: Right Drug, Wrong Dose at Seeking Alpha
Mar-02-14 11:58AM  The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28 at Forbes
Mar-01-14 07:31AM  3 Humongous Health-Care Stocks This Week at Motley Fool
06:45AM  Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results Other
Feb-22-14 12:45PM  Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors at Seeking Alpha
Feb-21-14 09:03AM  Biotech Stock Mailbag: Raptor, Chelsea, Oncogenex, More Hate Mail! at TheStreet
07:30AM  SA PRO: Top Long And Short Ideas, Thursday February 20 at Seeking Alpha
Prana Biotechnology Limited, a development stage company, engages in the research and development of therapeutic drugs in Australia. The company offers PBT-2, a Phase IIa clinical trial product for the treatment of Alzheimer's disease. Its product is designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses. The company's product is also applied for other therapies, including age-related cataracts, Huntington disease, Creutzfeldt-Jakob disease, Motor Neuron disease, age-related macular degeneration, cancers, Parkinson's disease, and other neurodegenerative diseases. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.
ONVO Organovo Holdings, Inc. daily Stock Chart
ONVO [NASD]
Organovo Holdings, Inc.
Index- P/E- EPS (ttm)-0.40 Insider Own1.90% Shs Outstand112.59M Perf Week-11.97%
Market Cap231.94M Forward P/E- EPS next Y-0.36 Insider Trans- Shs Float98.78M Perf Month13.81%
Income-39.80M PEG- EPS next Q-0.10 Inst Own25.20% Short Float15.60% Perf Quarter-22.85%
Sales4.30M P/S53.94 EPS this Y8.20% Inst Trans4.71% Short Ratio19.08 Perf Half Y-31.56%
Book/sh0.55 P/B3.75 EPS next Y7.70% ROA-60.10% Target Price4.67 Perf Year-46.77%
Cash/sh0.49 P/C4.22 EPS next 5Y- ROE-65.50% 52W Range1.75 - 4.14 Perf YTD-39.23%
Dividend- P/FCF- EPS past 5Y17.20% ROI-61.90% 52W High-50.24% Beta3.02
Dividend %- Quick Ratio15.60 Sales past 5Y28.70% Gross Margin74.80% 52W Low17.71% ATR0.13
Employees113 Current Ratio15.70 Sales Q/Q11.10% Oper. Margin- RSI (14)45.39 Volatility6.85% 5.89%
OptionableYes Debt/Eq0.00 EPS Q/Q-1.70% Profit Margin- Rel Volume0.85 Prev Close2.03
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume807.82K Price2.06
Recom1.30 SMA20-0.82% SMA50-6.12% SMA200-28.25% Volume687,668 Change1.48%
Jan-25-17Initiated Raymond James Outperform
Aug-11-15Downgrade Cantor Fitzgerald Buy → Hold
Jun-29-15Initiated Piper Jaffray Overweight $5
Jun-29-15Initiated Jefferies Buy $5
Aug-30-17 03:43PM  Why Tiny Organovo Is Giving Money to Huge Biotech Amgen Motley Fool
Aug-23-17 08:05AM  Organovo Sponsors Pioneering Research With Amgen and Medikine in Critical Areas of Liver and Kidney Disease GlobeNewswire
Aug-14-17 02:20PM  Edited Transcript of ONVO earnings conference call or presentation 9-Aug-17 9:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 06:14PM  ETFs with exposure to Organovo Holdings, Inc. : August 11, 2017 Capital Cube
Aug-10-17 08:24AM  Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters Motley Fool
Aug-09-17 11:54PM  Organovo reports 1Q loss Associated Press
04:05PM  Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook GlobeNewswire
01:00PM  Investor Network: Organovo Holdings, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 09:40AM  LD Micro Index Reconstitution as of August 1, 2017 ACCESSWIRE -7.69%
Jul-31-17 05:01PM  ETFs with exposure to Organovo Holdings, Inc. : July 31, 2017 Capital Cube
08:05AM  Organovo and UC San Diego Receive $1.7 Million Grant From National Institutes of Health to Study Liver Disease GlobeNewswire
Jul-18-17 03:03PM  How Risky Is Organovo Holdings, Inc.? Motley Fool
08:05AM  Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results GlobeNewswire
Jul-13-17 04:22PM  ETFs with exposure to Organovo Holdings, Inc. : July 13, 2017 Capital Cube
Jul-10-17 10:17AM  Here's Why Organovo Holdings Inc Fell 10.5% in June Motley Fool
Jul-03-17 03:36PM  ETFs with exposure to Organovo Holdings, Inc. : July 3, 2017 Capital Cube
Jun-22-17 04:09PM  ETFs with exposure to Organovo Holdings, Inc. : June 22, 2017 Capital Cube
03:24PM  3 Reasons Organovo Holdings, Inc. Stock Could Fall Even More Motley Fool
08:15AM  Featured Company News - Pamplona to Acquire PAREXEL; Another Contract Researcher Goes Private Accesswire
Jun-13-17 09:45AM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q4, 2017 By the Numbers : June 13, 2017 Capital Cube
Jun-12-17 02:18PM  ETFs with exposure to Organovo Holdings, Inc. : June 12, 2017 Capital Cube
Jun-09-17 11:01AM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: 2017 By the Numbers : June 9, 2017 Capital Cube
Jun-08-17 04:15PM  Edited Transcript of ONVO earnings conference call or presentation 7-Jun-17 9:00pm GMT Thomson Reuters StreetEvents
09:21AM  Organovo Holdings Still Not Back on Track Motley Fool
08:00AM  Today's Research Reports on Stocks to Watch: PTC Therapeutics and Organovo Accesswire
Jun-07-17 04:31PM  Organovo reports 4Q loss Associated Press
04:05PM  Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook GlobeNewswire
Jun-05-17 08:05AM  Organovo to Present at Jefferies Healthcare Conference GlobeNewswire
May-29-17 08:09AM  Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : May 29, 2017 Capital Cube
May-24-17 09:30AM  3 Stocks That Could Put Amazon.com's Returns to Shame Motley Fool
May-18-17 08:05AM  Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues at World Advanced Therapies and Regenerative Medicine Congress GlobeNewswire
May-17-17 08:06AM  Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : May 17, 2017 Capital Cube
08:05AM  Organovo Announces Release Date for Fiscal Fourth-Quarter 2017 Financial Results GlobeNewswire
May-11-17 06:44AM  Here's Why Organovo Holdings Stock Fell 5.2% In April Motley Fool
May-03-17 04:50PM  Organovo Holdings, Inc. Value Analysis (NASDAQ:ONVO) : May 3, 2017 Capital Cube
May-02-17 08:09AM  Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : May 2, 2017 Capital Cube -5.72%
May-01-17 08:05AM  Organovo Collaborates With University of Virginia to Develop Bioprinted Tissues for Volumetric Muscle Loss Injury GlobeNewswire
Apr-24-17 05:00PM  Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Apr-18-17 05:43PM  Why Organovo Holdings Inc Shareholders Have Something to Worry About Motley Fool
Apr-12-17 09:32AM  Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents TheStreet.com -6.58%
09:23AM  Organovo Holdings CEO Leaves: Should Investors Be Worried? Motley Fool
Apr-11-17 04:05PM  Organovo Announces CEO Transition GlobeNewswire
07:23AM  What's Next for Organovo Holdings Inc.? Motley Fool
Apr-07-17 05:14PM  ETFs with exposure to Organovo Holdings, Inc. : April 7, 2017 Capital Cube
Mar-13-17 08:05AM  Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver and Kidney Tissues for Drug Toxicity Testing GlobeNewswire
Mar-09-17 08:05AM  Organovo to Present at 29th Annual Roth Conference GlobeNewswire
Mar-06-17 11:08AM  Here's Why Organovo Holdings Inc Dipped 15.7% in February Motley Fool
11:08AM  Here's Why Organovo Holdings Inc Dipped 15.7% in February at Motley Fool
Feb-28-17 11:03AM  3 Stocks to Avoid in Biotech Motley Fool
11:03AM  3 Stocks to Avoid in Biotech at Motley Fool
Feb-22-17 05:08PM  Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation Motley Fool
05:08PM  Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation at Motley Fool
Feb-21-17 08:05AM  Organovo Publishes Data Describing Physiology of 3D Bioprinted Human Kidney Tissues for Drug Toxicity Testing GlobeNewswire
Feb-15-17 01:04PM  ORGANOVO HOLDINGS, INC. Financials
12:30PM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 15, 2017 Capital Cube
12:30PM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 15, 2017
Feb-10-17 04:44PM  Why Yelp, Organovo Holdings, and Ubiquiti Networks Slumped Today Motley Fool -15.38%
04:44PM  Why Yelp, Organovo Holdings, and Ubiquiti Networks Slumped Today at Motley Fool
12:26PM  Edited Transcript of ONVO earnings conference call or presentation 9-Feb-17 10:00pm GMT Thomson Reuters StreetEvents
09:14AM  Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News
Feb-09-17 10:49PM  Organovo Holdings' Unpleasant Q3 Surprise: Still Plenty of Skepticism About 3D Tissues at Motley Fool
05:00PM  Organovo Holdings Inc Earnings Call scheduled for 5:00 pm ET today
04:59PM  Organovo reports 3Q loss
04:07PM  ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:05PM  Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook GlobeNewswire
07:07AM  Q3 2017 Organovo Holdings Inc Earnings Release - Before Market Open
Jan-26-17 07:27AM  What to Expect in Organovo Holdings Inc. Q3 Results at Motley Fool
Jan-25-17 09:21AM  Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo +6.88%
07:37AM  Coverage initiated on Organovo by Raymond James
Jan-24-17 08:11AM  Organovo Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ONVO-US : January 24, 2017
08:05AM  Organovo Collaborates With Professor Melissa Little for Kidney Tissue Research GlobeNewswire
Jan-19-17 08:05AM  Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results GlobeNewswire
Jan-06-17 09:21AM  Organovo Holdings Inc.'s 36% Ascent in 2016 Can Be Attributed to These 3 Factors at Motley Fool
Jan-05-17 12:56PM  Better Buy: Organovo Holdings, Inc. vs. Akebia Therapeutics, Inc. at Motley Fool
Jan-04-17 09:30AM  The Zacks Analyst Blog Highlights: Codexis, EMCORE, Intevac, Organovo Holdings and StarTek +6.16%
Jan-03-17 05:05PM  Stock Market Roundup, Jan. 3: Ford Cancels Mexico Plant, 2017 IPOs in Focus +7.82%
02:29PM  5 of the Best Stocks Under $10 for 2017
Dec-30-16 11:20AM  ETFs with exposure to Organovo Holdings, Inc. : December 30, 2016
Dec-24-16 12:07PM  Will 2017 Be Organovo Holdings, Inc.'s Best Year Yet? at Motley Fool
Dec-20-16 12:51PM  When Will Organovo Holdings Finally Start Making Money? at Motley Fool
Dec-19-16 02:06PM  Forget Marijuana Stocks: Buy These 3 Biotech Stocks Instead at Motley Fool
Dec-14-16 08:05AM  Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan) GlobeNewswire
Dec-13-16 12:22PM  Organovo Holdings, Inc.'s Biggest Win in 2016 at Motley Fool +11.80%
11:48AM  Why Organovo Holdings, Inc. Stock Spiked Today at Motley Fool
08:05AM  Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting GlobeNewswire
Dec-12-16 09:02PM  Is Organovo Holdings Inc (ONVO) A Good Stock to Buy? at Insider Monkey
10:28AM  Organovo Holdings, Inc. Value Analysis (NASDAQ:ONVO) : December 12, 2016
Dec-09-16 07:23AM  Organovo Holdings, Inc. breached its 50 day moving average in a Bullish Manner : ONVO-US : December 9, 2016
Dec-08-16 12:53PM  ETFs with exposure to Organovo Holdings, Inc. : December 8, 2016 +6.80%
Dec-07-16 08:18AM  Here's Why Organovo Holdings Inc. Vaulted 11% in November at Motley Fool
08:05AM  Organovo to Present on December 14 in a Live Interactive Webcast at VirtualInvestorConferences.com PR Newswire
Dec-01-16 03:52PM  Watch These 3-D Printing Stocks Ahead of Global 3-D Printing Day
07:48AM  3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come at Motley Fool
Nov-28-16 12:24PM  ETFs with exposure to Organovo Holdings, Inc. : November 28, 2016
Nov-22-16 08:05AM  Organovo to Present at 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-21-16 02:40PM  Investors Are 3-D Printing Their Gains
Nov-14-16 08:05AM  Organovo to Present at 2016 Canaccord Genuity Medical Technologies & Diagnostics Forum GlobeNewswire
Nov-10-16 08:12AM  How Much Is Organovo Holdings, Inc. Really Worth? at Motley Fool +5.25%
Nov-08-16 12:29PM  ETFs with exposure to Organovo Holdings, Inc. : November 8, 2016
Nov-07-16 11:04AM  Organovo Holdings, Inc. :ONVO-US: Earnings Analysis: Q2, 2017 By the Numbers : November 7, 2016
Organovo Holdings, Inc., an early commercial stage company, designs and creates functional and three-dimensional (3D) human tissues for use in medical research and therapeutic applications. The company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic, and other partners. Its 3D human tissues could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company offers two commercial products, which include ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing a suite of standardized and 3D human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology, or disease for use in drug discovery and development, and disease modeling; and 3D human tissues for clinical applications, such as therapeutic liver tissue patch. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.
LCI Lannett Company, Inc. daily Stock Chart
LCI [NYSE]
Lannett Company, Inc.
Index- P/E- EPS (ttm)-0.03 Insider Own2.40% Shs Outstand37.17M Perf Week-8.26%
Market Cap618.88M Forward P/E6.05 EPS next Y2.75 Insider Trans0.00% Shs Float28.11M Perf Month6.73%
Income-0.60M PEG- EPS next Q0.52 Inst Own90.50% Short Float59.61% Perf Quarter-13.51%
Sales637.30M P/S0.97 EPS this Y-101.30% Inst Trans-7.75% Short Ratio29.03 Perf Half Y-20.14%
Book/sh15.21 P/B1.09 EPS next Y7.05% ROA0.00% Target Price23.00 Perf Year-48.71%
Cash/sh3.90 P/C4.27 EPS next 5Y-9.64% ROE-0.10% 52W Range14.90 - 33.53 Perf YTD-24.49%
Dividend- P/FCF3.74 EPS past 5Y-16.10% ROI5.80% 52W High-50.34% Beta2.76
Dividend %- Quick Ratio2.10 Sales past 5Y39.00% Gross Margin47.90% 52W Low11.74% ATR0.76
Employees1126 Current Ratio2.70 Sales Q/Q-17.60% Oper. Margin13.60% RSI (14)39.61 Volatility4.29% 4.60%
OptionableYes Debt/Eq1.61 EPS Q/Q58.80% Profit Margin-0.10% Rel Volume0.39 Prev Close16.55
ShortableYes LT Debt/Eq1.50 EarningsAug 23 AMC Payout- Avg Volume577.23K Price16.65
Recom2.40 SMA20-2.84% SMA50-8.52% SMA200-20.43% Volume226,498 Change0.60%
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Sep-11-13Reiterated Oppenheimer Outperform $15 → $20
May-23-13Initiated Needham Buy $15
Feb-08-13Reiterated Oppenheimer Outperform $6 → $9
Sep-08-11Reiterated Oppenheimer Outperform $7 → $6
Sep-13-17 07:00AM  Earnings Review and Free Research Report: Lannetts Sales and Earnings Results Met Expectations ACCESSWIRE
Sep-06-17 05:02PM  What Is Lannett Company Incs (LCI) Share Price Doing? Simply Wall St.
Sep-05-17 03:30PM  Lannett receives FDA OK for generic Nexium product American City Business Journals
09:45AM  Lannett Scores FDA OK for Nexium Generic-Biotech Movers TheStreet.com
06:53AM  Lannett Receives Approval For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg PR Newswire
Sep-01-17 08:10PM  ETFs with exposure to Lannett Co., Inc. : September 2, 2017 Capital Cube
Aug-30-17 01:30PM  Lannett Co., Inc. :LCI-US: Earnings Analysis: 2017 By the Numbers : August 30, 2017 Capital Cube
Aug-24-17 08:26PM  Edited Transcript of LCI earnings conference call or presentation 23-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
10:57AM  Lannett (LCI) Q4 Earnings In Line, Stock Up on Solid View Zacks
Aug-23-17 09:46PM  Lannett posts 4Q profit Associated Press
04:24PM  Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018 PR Newswire
10:00AM  Investor Network: Lannett Company, Inc. to Host Earnings Call ACCESSWIRE
Aug-15-17 06:06PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : August 15, 2017 Capital Cube
Aug-08-17 06:54AM  Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook PR Newswire
Aug-07-17 04:21PM  3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping? Motley Fool
Aug-05-17 08:27AM  Teva, Mylan Seen to Stay on M&A Sidelines TheStreet.com
Aug-03-17 07:02AM  Take a Look at 5 Stocks with Attractive Price-to-Book Ratio Zacks -8.00%
Aug-02-17 11:29AM  Zacks.com featured highlights: Vishay Intertechnology, Big Lots, Applied Materials and Lannett Company Zacks -6.95%
09:14AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : August 2, 2017 Capital Cube
Aug-01-17 08:08AM  4 Low Price-to-Cash-Flow Stocks for Assured Returns Zacks
06:53AM  Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9 PR Newswire
Jul-24-17 04:57PM  ETFs with exposure to Lannett Co., Inc. : July 24, 2017 Capital Cube
Jul-17-17 09:01AM  Fox Rothschild partner becomes general counsel of local drug manufacturer American City Business Journals
07:20AM  Corporate News Blog - Lannett Co. Receives Approval for Cyproheptadine Hydrochloride Syrup Accesswire
06:53AM  Lannett Appoints Samuel H. Israel As General Counsel PR Newswire
Jul-14-17 06:53AM  Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL PR Newswire +6.57%
Jul-12-17 02:46PM  ETFs with exposure to Lannett Co., Inc. : July 12, 2017 Capital Cube
Jul-04-17 08:57AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : July 4, 2017 Capital Cube
Jun-28-17 08:15AM  Corporate News Blog - Lannett Receives Approval for Additional Dosage Strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP Accesswire
Jun-26-17 06:51AM  Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP PR Newswire
Jun-22-17 06:53AM  Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg PR Newswire
Jun-20-17 06:52AM  Lannett Names Patrick G. LePore To Board of Directors PR Newswire
Jun-19-17 03:38PM  ETFs with exposure to Lannett Co., Inc. : June 19, 2017 Capital Cube
08:15AM  Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season Accesswire
06:53AM  Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg PR Newswire
Jun-16-17 11:49AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
06:53AM  Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg PR Newswire
May-26-17 06:53AM  Lannett Company's Chief Executive Officer Receives High Rating PR Newswire
May-16-17 06:52AM  Lannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) PR Newswire
May-09-17 06:53AM  Lannett Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility PR Newswire
May-05-17 05:08PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : May 5, 2017 Capital Cube
May-04-17 02:16PM  Edited Transcript of LCI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
08:53AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : May 4, 2017 Capital Cube
May-03-17 01:07PM  Here's Why Lannett Company, Inc. Is Having a Lousy Day Motley Fool -18.60%
12:46PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
May-02-17 07:41PM  Lannett misses Street 3Q forecasts Associated Press
04:15PM  Lannett Reports Fiscal 2017 Third-Quarter Financial Results PR Newswire
Apr-28-17 06:54AM  Lannett To Participate At Three Investor Conferences In May PR Newswire
Apr-25-17 06:54AM  Lannett To Report Fiscal 2017 Third-Quarter Financial Results, Host Conference Call On Tuesday, May 2 PR Newswire
Apr-24-17 09:40AM  Lawsuit for Investors in NYSE: LCI Shares against Lannett Company, Inc Announced by Shareholders Foundation Accesswire
Apr-10-17 04:31PM  Akorn Acquisition Talks Send Generic Drugmakers Into Orbit Investor's Business Daily +10.59%
Apr-04-17 08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017 Capital Cube
08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017
Apr-03-17 12:14PM  Lannett Refuses to Go Lower TheStreet.com
12:14PM  Lannett Refuses to Go Lower
Mar-30-17 06:53AM  Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility PR Newswire
Mar-29-17 11:31AM  Trading Five Volatility Squeeze Plays
Mar-27-17 06:54AM  Lannett Announces Passing Of Former Chairman And Chief Executive Officer William Farber PR Newswire
Mar-24-17 02:43PM  3 Top Generic Drug Companies to Buy in 2017 Motley Fool
02:43PM  3 Top Generic Drug Companies to Buy in 2017 at Motley Fool
Mar-21-17 09:40AM  Is Lannett (LCI) a Great Stock for Value Investors? Zacks
09:40AM  Is Lannett (LCI) a Great Stock for Value Investors?
Mar-20-17 08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017 Capital Cube
08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017
Mar-10-17 09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems Zacks
09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Feb-27-17 06:53AM  Lannett To Participate At Four Upcoming Investor Conferences PR Newswire
Feb-23-17 06:53AM  Lannett Announces Addition To Management Team PR Newswire
Feb-22-17 11:25AM  FDA gives Lannett more time to make its case for ADHD drug at bizjournals.com
06:54AM  Lannett Provides Further Update On Methylphenidate ER Tablets PR Newswire
Feb-16-17 10:13AM  Will Lannett (LCI) Continue to Surge Higher?
Feb-13-17 12:55PM  Weekly CEO Buys Highlights
Feb-08-17 05:18PM  CEO Buys Shares of Lannett
01:04PM  LANNETT CO INC Financials
Feb-07-17 11:23AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017
10:22AM  Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
09:15AM  Board Member at Beleaguered Burrito Chain Buys Shares After Barrons Releases Grim Cover Story, Plus Other Noteworthy Insider Trading Activity at Insider Monkey
06:54AM  Lannett Announces Successful Completion Of ERP System Extraction PR Newswire
Feb-06-17 08:20AM  Affimed (AFMD) Shows Strength: Stock Moves 8.1% Higher
08:00AM  AcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3%
Feb-03-17 08:57AM  LANNETT CO INC Files SEC form 10-Q, Quarterly Report -8.06%
Feb-02-17 04:16PM  LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition
Feb-01-17 10:39PM  Edited Transcript of LCI earnings conference call or presentation 1-Feb-17 9:30pm GMT
05:48PM  Lannett tops Street 2Q forecasts
04:15PM  Lannett Reports Fiscal 2017 Second-Quarter Financial Results PR Newswire
07:07AM  Q2 2017 Lannett Company Inc Earnings Release - After Market Close
Jan-30-17 01:42PM  5 Earnings Short-Squeeze Trade Ideas
Jan-25-17 08:11PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI PR Newswire
05:03PM  LANNETT CO INC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
06:54AM  Lannett To Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 1 PR Newswire
Jan-23-17 03:05PM  Robbins Arroyo LLP: Lannett Company, Inc. (LCI) Misled Shareholders According to a Recently Filed Class Action Business Wire
08:27AM  Lannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility PR Newswire
Jan-19-17 05:34PM  LANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:03PM  Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, In PR Newswire
Jan-13-17 02:49PM  Harwood Feffer LLP Announces Investigation of Lannett Company Inc. PR Newswire
11:40AM  Bernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A Class Action Suit Against Lannett Company, Inc. PR Newswire
10:47AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Jan-12-17 05:10PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI PR Newswire
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEDROSIAN ARTHUR PCEOFeb 06Buy20.0010,000200,000688,909Feb 06 05:14 PM
FARBER DAVID10% OwnerDec 13Sale25.002005,0001,930,870Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 09Sale25.306,000151,8001,931,070Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 02Sale25.003,80095,0001,937,070Dec 05 04:29 PM
FARBER JEFFREYDirectorNov 07Option Exercise6.895,00034,4502,438,826Nov 08 05:49 PM
SODA SodaStream International Ltd. daily Stock Chart
SODA [NASD]
SodaStream International Ltd.
Index- P/E21.93 EPS (ttm)2.70 Insider Own6.37% Shs Outstand21.70M Perf Week0.24%
Market Cap1.28B Forward P/E19.85 EPS next Y2.98 Insider Trans0.00% Shs Float21.70M Perf Month3.05%
Income- PEG1.46 EPS next Q0.73 Inst Own54.65% Short Float4.44% Perf Quarter13.18%
Sales501.96M P/S2.56 EPS this Y32.40% Inst Trans-194.57% Short Ratio4.30 Perf Half Y25.23%
Book/sh20.14 P/B2.94 EPS next Y8.80% ROA- Target Price55.63 Perf Year129.75%
Cash/sh- P/C- EPS next 5Y15.00% ROE- 52W Range23.77 - 63.25 Perf YTD49.89%
Dividend- P/FCF- EPS past 5Y4.26% ROI- 52W High-6.47% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low148.89% ATR1.27
Employees1686 Current Ratio- Sales Q/Q9.60% Oper. Margin- RSI (14)51.05 Volatility1.72% 2.09%
OptionableYes Debt/Eq- EPS Q/Q83.90% Profit Margin- Rel Volume0.43 Prev Close59.08
ShortableYes LT Debt/Eq- EarningsAug 02 BMO Payout- Avg Volume224.30K Price59.16
Recom2.60 SMA20-0.36% SMA501.60% SMA20016.93% Volume97,036 Change0.14%
Aug-03-17Upgrade Susquehanna Neutral → Positive
Aug-03-16Downgrade ROTH Capital Buy → Neutral
May-12-16Reiterated Jefferies Hold $15 → $17
Dec-16-15Initiated Jefferies Hold
Nov-05-15Reiterated Deutsche Bank Hold $18 → $16
Nov-05-15Downgrade Susquehanna Positive → Neutral
Jun-18-15Reiterated ROTH Capital Buy $24 → $29
May-07-15Upgrade ROTH Capital Neutral → Buy
Apr-14-15Initiated Susquehanna Positive $24
Jan-22-15Upgrade Stifel Sell → Hold
Oct-30-14Reiterated Deutsche Bank Hold $32 → $22
Oct-07-14Downgrade ROTH Capital Buy → Neutral $48 → $24
Jul-31-14Upgrade Barclays Underweight → Equal Weight $35
Jul-16-14Reiterated Deutsche Bank Hold $37 → $32
May-22-14Downgrade Barclays Equal Weight → Underweight $40 → $35
Feb-27-14Reiterated Deutsche Bank Hold $53 → $37
Feb-06-14Reiterated Canaccord Genuity Hold $43 → $39
Jan-27-14Reiterated Barclays Overweight $100 → $55
Jan-15-14Reiterated Canaccord Genuity Hold $63 → $43
Jan-13-14Reiterated Deutsche Bank Hold $58 → $53
Sep-19-17 03:07PM  Delta Apparel's (DLA) Buyback Program Disappoints Investors Zacks
Sep-14-17 09:46AM  Here's Why You Should Add SodaStream (SODA) to Your Portfolio Zacks
Sep-07-17 06:51PM  3 Health Food Stocks to Buy Right Now Zacks
Aug-30-17 09:01AM  5 Top-Ranked Stocks to Buy on Record Consumer Confidence Zacks
Aug-27-17 10:00AM  Edited Transcript of SODA earnings conference call or presentation 2-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-24-17 10:34AM  Guess? (GES) Posts Upbeat Q2 Earnings & Sales, Raises View Zacks
Aug-23-17 08:13AM  This May Be the Only Way for Blue Apron to Survive Motley Fool
Aug-17-17 11:25AM  The Zacks Analyst Blog Highlights: Nutrisystem, Malibu Boats, SodaStream International, Royal Caribbean Cruises and Bright Horizons Family Solutions Zacks
Aug-16-17 06:42PM  ETFs with exposure to SodaStream International Ltd. : August 16, 2017 Capital Cube
08:47AM  Ignore Retail: 5 Other Stocks Gaining from a Bolder Consumer Zacks
08:00AM  3 Stocks That Could Put Alibaba's Returns to Shame Motley Fool
Aug-11-17 07:40AM  Earnings Review and Free Research Report: Dr Pepper Snapples Revenue Grew 6%, Beating Expectations ACCESSWIRE
Aug-09-17 09:51AM  Guess' Focuses on International Expansion: Time to Hold? Zacks
Aug-08-17 09:30AM  Hanesbrands' (HBI) Stock Benefits from Acquisition Yields Zacks
Aug-07-17 10:12AM  Can SodaStream Keep Going After Last Week's 9% Pop? Motley Fool
Aug-04-17 05:10PM  SodaStream International Ltd.: Leads amongst peers with strong fundamentals Capital Cube
Aug-03-17 04:30PM  Why Fitbit, SodaStream International, and Stamps.com Jumped Today Motley Fool +13.25%
02:14PM  SodaStream Delivers Flavorful Q2 Beat, Earns An Upgrade Benzinga
01:31PM  SodaStream International Ltd. :SODA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017 Capital Cube
11:01AM  Why SodaStream is Soaring Barrons.com
12:16AM  SodaStream posts 2Q profit Associated Press
Aug-02-17 06:32PM  SodaStream International Ltd (SODA) Shares Fall Despite Earnings Beat InvestorPlace
12:40PM  SodaStream Second-Quarter Earnings Jump 84% Motley Fool
09:01AM  SodaStream (SODA) Surpasses Q2 Earnings & Sales Estimates Zacks
07:40AM  SodaStream shares rise after earnings and revenue beat expectations MarketWatch
07:30AM  SodaStream Reports Second Quarter Fiscal 2017 Results PR Newswire
Aug-01-17 10:33AM  SodaStream International (SODA) Q2 Earnings: What's in Store? Zacks
Jul-26-17 08:21AM  3 Growth Stocks That Could Soar More Than Dollar Tree Motley Fool
Jul-19-17 07:30AM  SodaStream Schedules the Release of its Second Quarter 2017 Financial Results for Wednesday, August 2, 2017 PR Newswire
Jul-18-17 05:30PM  3 Stocks Warren Buffett Can't Buy, but You Can Motley Fool
Jul-17-17 09:35AM  SodaStream targets organic growth, hopes to employ more Palestinians Reuters
08:15AM  SodaStream International Ltd. breached its 50 day moving average in a Bullish Manner : SODA-US : July 17, 2017 Capital Cube
Jul-16-17 03:00PM  Our Biggest Soda Rivals Are Prehistoric and They Keep Trying to Shut Us Up: SodaStream CEO TheStreet.com
Jul-14-17 12:33PM  Why SodaStream International Stock Is Up 34% This Year Motley Fool
09:30AM  The Zacks Analyst Blog Highlights: Crescent Point Energy, Vertex Pharmaceuticals, SodaStream International, Commercial Vehicle Group and Melco Crown Entertainment Zacks
01:00AM  SodaStream Launches New Viral Video Featuring The Big Bang Theory Star Mayim Bialik and Game of Thrones Star Kristian Nairn PR Newswire
01:00AM  SodaStream Launches New Viral Video Featuring The Big Bang Theory Star Mayim Bialik and Game of Thrones Star Kristian Nairn CNW Group
Jul-13-17 04:11PM  Nvidia Is Roaring, Activision Blizzard Is Screaming and Tech Is Back in a Big Way: Market Recon TheStreet.com
03:45PM  5 Companies That Consistently Beat Earnings Estimates Zacks
09:11AM  Can a Tiny Upstart Disrupt Big Beverage? Motley Fool
08:29AM  4 Reasons Why You Should Add SodaStream to Your Portfolio Zacks
Jul-12-17 07:29PM  Facebook Sends Mixed Signals; SodaStream Details Plan to Topple Beverage Giants -- ICYMI Wednesday TheStreet.com
04:15PM  Can Central Garden & Pet's Efforts Help Propel the Stock? Zacks
Jul-06-17 08:05AM  SodaStream's Integrated "Shame or Glory" Campaign Wins Gold at the Prestigious 2017 EMEA SABRE Awards Competition PR Newswire
Jul-04-17 08:07AM  SodaStream International Ltd. breached its 50 day moving average in a Bullish Manner : SODA-US : July 4, 2017 Capital Cube
Jun-30-17 09:22AM  SodaStream Up 340% Since February of 2016 Investopedia
Jun-29-17 10:29AM  SodaStream On the Offensive TheStreet.com
09:50AM  SodaStream on the Hunt for Acquisitions to Keep 340% Rally Going Bloomberg
Jun-23-17 12:11PM  Top Ranked Momentum Stocks to Buy for June 23rd Zacks
Jun-20-17 04:12PM  SodaStream International Ltd. Value Analysis (NASDAQ:SODA) : June 20, 2017 Capital Cube
Jun-19-17 08:35AM  SodaStream International Ltd. breached its 50 day moving average in a Bearish Manner : SODA-US : June 19, 2017 Capital Cube
Jun-14-17 08:00AM  Today's Research Reports on Stocks to Watch: SodaStream International and pSivida Corp. Accesswire
Jun-13-17 04:30PM  SodaStream (SODA) Climbs 6%, Should You Buy? Zacks +6.48%
04:27PM  The Kind Of Bubble You May Want In Stocks: Investing Action Plan Investor's Business Daily
04:01PM  SodaStream Explodes Higher After CEO Buys 20,000 Shares TheStreet.com
Jun-10-17 02:06PM  3 Growth Stocks for Bold Investors Motley Fool
Jun-08-17 12:07PM  Top Ranked Momentum Stocks to Buy for June 8th Zacks
Jun-06-17 09:00AM  Why You Shouldn't Bet Against SodaStream International (SODA) Stock Zacks
Jun-05-17 11:10AM  Top Ranked Momentum Stocks to Buy for June 5th Zacks
08:07AM  SodaStream International Ltd. breached its 50 day moving average in a Bullish Manner : SODA-US : June 5, 2017 Capital Cube
May-31-17 12:20PM  5 Top Ranked Stocks to Buy as Consumer Spending Expands Zacks
09:40AM  Top Ranked Momentum Stocks to Buy for May 31st Zacks
May-18-17 08:15AM  Post Earnings Coverage as Monster Beverage's Quarterly Sales Jumped 9.1%; EPS Climbed 15.8% Accesswire
May-16-17 11:10AM  Edited Transcript of SODA earnings conference call or presentation 10-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-15-17 03:29PM  SodaStream Puts Faith in its Rebranding Effort Investopedia
May-13-17 08:12AM  3 Winning Stocks You Never Saw Coming Motley Fool
May-12-17 04:31PM  ETFs with exposure to SodaStream International Ltd. : May 12, 2017 Capital Cube
08:45AM  Don't Be Fooled by the SodaStream Selloff Motley Fool
May-11-17 11:36AM  SodaStream International Ltd. :SODA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 11, 2017 Capital Cube
10:05AM  SodaStream International (SODA) Tops Q1 Earnings, Lifts View Zacks
08:00AM  Todays Research Reports on Stocks to Watch: SodaStream and Fossil Accesswire
May-10-17 09:15PM  Edited Transcript of SODA earnings conference call or presentation 10-May-17 12:30pm GMT Thomson Reuters StreetEvents -6.95%
04:24PM  Why Yelp, Vitamin Shoppe, and SodaStream International Slumped Today Motley Fool
04:09PM  SodaStream Stock Tumbles Why It May Be Time To Buy Investor's Business Daily
03:48PM  SodaStream Earnings Soar 129% on Spiking Machine and Refill Canister Sales Motley Fool
02:16PM  Story Stocks from Briefing.com Briefing.com
09:01AM  SodaStream (SODA) Surpasses Q1 Earnings & Sales Estimates Zacks
07:40AM  SodaStream posts 1Q profit Associated Press
07:39AM  SodaStream earnings beat estimates MarketWatch
07:30AM  SodaStream Reports First Quarter Fiscal 2017 Results PR Newswire
May-09-17 04:38PM  SodaStream International (SODA) Q1 Earnings: What's in Store? Zacks
May-08-17 09:29AM  Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks Investor's Business Daily
May-05-17 09:12AM  Why SodaStream International Ltd. Stock Gained 12% in April Motley Fool
Apr-27-17 12:12PM  3 Stocks That Could Have Doubled Your Money Motley Fool
Apr-26-17 07:30AM  SodaStream Schedules the Release of its First Quarter 2017 Financial Results for Wednesday, May 10, 2017 PR Newswire
Apr-13-17 10:10AM  Hanesbrands Issues Preliminary Q1 Results, 2017 View Intact Zacks
Apr-11-17 11:36AM  3 Stocks Are Up 150% Motley Fool
Apr-08-17 02:24PM  3 Top Soda Stocks to Buy in 2017 Motley Fool
01:00PM  As Pepsi Pulls Controversial Kendall Jenner Ad, Here's a Look Back at the Worst Commercials Ever TheStreet.com
Apr-05-17 04:34PM  SodaStream Takes Bold Stab at Rival Pepsi Investopedia
02:09PM  Sodastream CEO Rips Pepsi to Shreds for 'Tone Deaf' Kendall Jenner Soda Commercial TheStreet.com
Apr-04-17 07:52PM  Crude Bucks Choppy Trend - Dave's Daily Dive Zacks
06:55PM  Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
Apr-03-17 04:34PM  Why NovoCure, Lumber Liquidators, and SodaStream International Jumped Today Motley Fool +5.43%
09:39AM  Will Whirlpool's Focus on Strategic Innovation Drive Growth? Zacks
08:00AM  SodaStream Reveals April Fool's Day Prank with Paris Hilton Marketwired
02:00AM  SodaStream Reveals April Fools' Day Prank With Paris Hilton PR Newswire
Mar-30-17 09:30AM  The Zacks Analyst Blog Highlights: SodaStream International, SP Plus, Hasbro, Crown Crafts and Salem Media Group Zacks
09:30AM  The Zacks Analyst Blog Highlights: SodaStream International, SP Plus, Hasbro, Crown Crafts and Salem Media Group at Investopedia
07:07AM  Lululemon (LULU) Plunges on Q4 Earnings Miss & Bleak Q1 View Investopedia
SodaStream International Ltd., together with its subsidiaries, manufactures, distributes, and sells home beverage carbonation systems. Its home beverage carbonation systems, which enable consumers to transform ordinary tap water into sparkling water and flavored sparkling water. The company offers sparkling water makers and exchangeable carbon-dioxide (CO2) cylinders, as well as consumables, such as CO2 refills, reusable carbonation bottles, and flavors; and other accessories, such as bottle cleaning materials and ice cube trays, as well as distributes Brita water filtration systems in Israel. It markets its products directly; and through individual retail stores, local distributors, and online under the SodaStream and Soda-Club brand names. As of December 31, 2016, the company sells its products through approximately 80,000 individual retail stores in 45 countries. It operates in the Americas; Western Europe; the Asia-Pacific; and Central and Eastern Europe, the Middle East, and Africa. The company was formerly known as Soda-Club Holdings Ltd. and changed its name to SodaStream International Ltd. in March 2010. SodaStream International Ltd. was founded in 1903 and is headquartered in Airport City, Israel.